Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-028850
Filing Date
2012-05-15
Accepted
2012-05-14 21:48:43
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v312766_10q.htm 10-Q 515382
2 EXHIBIT 31.1 v312766_ex31-1.htm EX-31.1 9666
3 EXHIBIT 31.2 v312766_ex31-2.htm EX-31.2 9623
4 EXHIBIT 32.1 v312766_ex32-1.htm EX-32.1 4693
5 EXHIBIT 99.1 v312766_ex99-1.htm EX-99.1 27418
12 GRAPHIC logo.jpg GRAPHIC 13091
  Complete submission text file 0001144204-12-028850.txt   4033614

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adhxf-20120331.xml EX-101.INS 494916
7 XBRL TAXONOMY EXTENSION SCHEMA adhxf-20120331.xsd EX-101.SCH 17119
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adhxf-20120331_cal.xml EX-101.CAL 33898
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adhxf-20120331_def.xml EX-101.DEF 96813
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adhxf-20120331_lab.xml EX-101.LAB 158164
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adhxf-20120331_pre.xml EX-101.PRE 113049
Mailing Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703
Business Address 4620 CREEKSTONE DRIVE SUITE 200 DURHAM NC 27703 919-484-8484
ADHEREX TECHNOLOGIES INC (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 12840774
SIC: 2836 Biological Products, (No Diagnostic Substances)